🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 3 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/03/2016 50,09 50,94 48,48 48,66 -2,85% 4,91% 755.700
22/03/2016 47,69 51,16 47,69 50,09 +4,25% 7,28% 671.800
21/03/2016 47,57 49,00 47,14 48,05 +0,48% 3,91% 490.200
18/03/2016 45,63 47,93 45,16 47,82 +5,42% 6,07% 1.055.200
17/03/2016 48,34 48,50 44,15 45,36 -5,97% 9,00% 1.395.500
16/03/2016 50,00 52,08 47,64 48,24 -4,04% 8,88% 680.400
15/03/2016 53,36 53,36 49,91 50,27 -6,91% 6,47% 816.100
14/03/2016 52,38 55,14 51,66 54,00 +3,09% 6,64% 683.300
11/03/2016 51,08 52,74 50,49 52,38 +4,03% 4,40% 433.100
10/03/2016 51,28 51,99 49,70 50,35 -0,65% 4,47% 483.500
09/03/2016 50,17 50,96 48,01 50,68 +1,10% 5,88% 927.600
08/03/2016 53,87 54,69 50,00 50,13 -7,56% 8,71% 578.500
07/03/2016 53,82 55,36 52,92 54,23 -0,04% 4,53% 517.300
04/03/2016 54,43 55,45 53,16 54,25 +0,00% 4,21% 517.500
03/03/2016 54,47 55,24 53,63 54,25 -0,59% 2,96% 491.700
02/03/2016 50,87 54,62 50,06 54,57 +6,73% 8,96% 747.700
01/03/2016 51,95 52,63 50,05 51,13 -1,69% 4,97% 1.050.500
29/02/2016 55,87 55,89 49,68 52,01 -7,16% 11,12% 1.750.800
26/02/2016 57,43 58,47 51,50 56,02 -2,17% 12,14% 2.323.800
25/02/2016 55,05 61,92 55,00 57,26 -3,94% 12,57% 1.422.500
24/02/2016 59,56 60,64 57,59 59,61 -1,29% 5,12% 911.800
23/02/2016 62,84 63,20 59,91 60,39 -4,45% 5,24% 502.200
22/02/2016 62,50 64,18 61,58 63,20 +2,88% 4,16% 910.100
19/02/2016 59,86 61,78 59,00 61,43 +2,09% 4,64% 564.300
18/02/2016 62,14 62,38 58,64 60,17 -2,86% 6,02% 410.700
17/02/2016 60,00 62,75 58,00 61,94 +4,15% 7,92% 643.600
16/02/2016 58,14 60,00 57,03 59,47 +4,26% 5,11% 575.900
12/02/2016 57,05 59,90 55,29 57,04 +1,35% 8,08% 458.800
11/02/2016 56,48 56,76 53,54 56,28 -2,83% 5,70% 565.300
10/02/2016 58,46 60,80 57,50 57,92 +0,38% 5,64% 533.100